Treatment of gastrointestinal neuroendocrine tumours
CPD Previous     Next

Treatment of gastrointestinal neuroendocrine tumours

Louise Causer Clinical nurse specialist in nuclear medicine, Royal Marsden NHS Foundation Trust, Sutton, Surrey
Barbara King Neuroendocrine tumour and research liaison nurse, Basingstoke and North Hampshire NHS Foundation Trust

Neuroendocrine tumours are rare, accounting for only 0.5 per cent of all malignancies. This is an often misdiagnosed and under-recognised condition that can lead to years of inadequately managed symptoms, leaving patients feeling distressed, isolated and frustrated. The nurse specialist can educate patients, co-ordinate and implement integrated care and administer symptomatic treatments. A major goal is to improve patients’ experiences by working with all members of the multidisciplinary team.

Cancer Nursing Practice. 9, 7, 28-37. doi: 10.7748/cnp2010.

Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to the website and the online archive
  • Bi-monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now